Table 3. Summary risk estimates of the association between parity number and gastric cancer risk.
Highest vs. lowest |
Dose-response analysis (per 1 live birth) |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Study | SRR | 95% CI | I2 (%) | Ph† | Ph‡ | No. of Study | SRR | 95% CI | I2 (%) | Ph† | Ph‡ | |
Overall | 10 | 1.03 | 0.94–1.13 | 1.6 | 0.427 | 9 | 1.00 | 0.97–1.03 | 18.6 | 0.272 | ||
Subgroup analyses | ||||||||||||
Number of cases | 0.693 | 0.826 | ||||||||||
≥250 | 5 | 1.04 | 0.94–1.14 | 8.7 | 0.361 | 4 | 1.00 | 0.96–1.04 | 45.7 | 0.118 | ||
<250 | 5 | 0.96 | 0.67–1.38 | 11.1 | 0.343 | 5 | 1.00 | 0.94–1.05 | 0 | 0.454 | ||
Follow-up years | 0.618 | 0.217 | ||||||||||
≥10 | 5 | 1.06 | 0.89–1.25 | 31.5 | 0.199 | 4 | 1.01 | 0.97–1.06 | 46.9 | 0.110 | ||
<10 | 5 | 1.01 | 0.89–1.15 | 0 | 0.607 | 5 | 0.97 | 0.92–1.02 | 0 | 0.802 | ||
Geographic location | 0.976 | 0.968 | ||||||||||
Europe | 5 | 1.02 | 0.92–1.13 | 0 | 0.690 | 4 | 0.99 | 0.97–1.02 | 0 | 0.707 | ||
Asia | 4 | 0.98 | 0.67–1.42 | 51.1 | 0.105 | 4 | 0.99 | 0.91–1.07 | 60.2 | 0.057 | ||
North America | 1 | 0.83 | 0.47–1.47 | N/A | N/A | 1 | 0.96 | 0.81–1.13 | N/A | N/A | ||
Menopausal status | 0.794 | 0.831 | ||||||||||
Pre-menopausal | 1 | 0.80 | 0.46–1.40 | N/A | N/A | 1 | 0.93 | 0.77–1.12 | N/A | N/A | ||
Post-menopausal | 3 | 0.90 | 0.76–1.07 | 0 | 0.468 | 3 | 0.97 | 0.94–1.00 | 0 | 0.773 | ||
Anatomic subsite | 0.879 | 0.342 | ||||||||||
Cardia | 2 | 1.04 | 0.80-1.34 | 0 | 0.566 | 2 | 0.93 | 0.82–1.05 | 49.4 | 0.160 | ||
Non-cardia | 3 | 1.01 | 0.85–1.20 | 13.2 | 0.316 | 3 | 0.99 | 0.96–1.02 | 0 | 0.876 | ||
Adjustment for potential confounders and risk factors | ||||||||||||
Age | 0.276 | 0.939 | ||||||||||
Yes | 7 | 1.06 | 0.96–1.18 | 0 | 0.538 | 6 | 0.99 | 0.94–1.05 | 43.1 | 0.118 | ||
No | 3 | 0.94 | 0.72–1.22 | 20.4 | 0.288 | 3 | 0.99 | 0.97–1.02 | 0 | 0.626 | ||
Cigarette smoking | 0.618 | 0.217 | ||||||||||
Yes | 5 | 1.01 | 0.89–1.15 | 0 | 0.607 | 4 | 0.97 | 0.92–1.02 | 0 | 0.802 | ||
No | 5 | 1.06 | 0.89–1.25 | 31.5 | 0.199 | 5 | 1.01 | 0.97–1.06 | 46.9 | 0.110 | ||
Body mass index | 0.938 | 0.285 | ||||||||||
Yes | 4 | 1.03 | 0.90–1.17 | 0 | 0.857 | 4 | 0.97 | 0.92–1.02 | 0 | 0.652 | ||
No | 6 | 1.03 | 0.86–1.23 | 36.1 | 0.153 | 5 | 1.01 | 0.97–1.05 | 37.2 | 0.159 | ||
Alcohol drinking | 0.475 | 0.323 | ||||||||||
Yes | 3 | 0.96 | 0.77–1.20 | 16.7 | 0.301 | 3 | 0.97 | 0.92–1.03 | 0 | 0.993 | ||
No | 7 | 1.06 | 0.93–1.20 | 6.4 | 0.381 | 6 | 1.01 | 0.97–1.05 | 38.2 | 0.137 | ||
Socioeconomic status | 0.257 | 0.056 | ||||||||||
Yes | 5 | 0.99 | 0.90–1.10 | 0 | 0.753 | 5 | 0.98 | 0.96–1.01 | 0 | 0.836 | ||
No | 5 | 1.10 | 0.87–1.38 | 33.7 | 0.196 | 4 | 1.03 | 0.98–1.09 | 24.6 | 0.264 |
CI, confidence interval; N/A, not available; SRR, summarized relative risk.
†P-value for heterogeneity within each subgroup.
‡P-value for heterogeneity between subgroups with meta-regression analysis.